Bover J - Search Results

1

Tables for estimating the glomerular filtration rate using the new CKD-EPI equation from serum creatinine concentration.

Canal C, Pellicer R, Facundo C, Gràcia-Garcia S, Montañés-Bermúdez R, Ruiz-García C, Furlano M, Da Silva IK, Ballarín JA, Bover J. Canal C, et al. Among authors: bover j. Nefrologia. 2014;34(2):223-9. doi: 10.3265/Nefrologia.pre2013.Dec.12226. Nefrologia. 2014. PMID: 24658198 Free article. English, Spanish.

2

[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].

Bover J, Ortiz-Herbener F, Ballarín J, Andrés E, Barceló P. Bover J, et al. Nefrologia. 2005;25 Suppl 2:100-8. Nefrologia. 2005. PMID: 16050412 Free article. Review. Spanish.

3

[New therapeutic strategies in secondary hyperparathyroidism on dialysis (II): vitamin D analogues and calcium-mimetics].

Bover J, Ballarín J, Andrés E, Ortiz-Herbener F, Barceló P. Bover J, et al. Nefrologia. 2005;25 Suppl 2:109-16. Nefrologia. 2005. PMID: 16050413 Free article. Review. Spanish.

4

[Recommendations for the use of equations to estimate glomerular filtration rate in adults. Spanish Society of Nephrology].

Gracia S, Montañés R, Bover J, Cases A, Deulofeu R, Martín de Francisco AL, Orte LM; Sociedad Española de Nefrología. Gracia S, et al. Among authors: bover j. Nefrologia. 2006;26(6):658-65. Nefrologia. 2006. PMID: 17227242 Free article. Spanish. No abstract available.

5

Diagnostic procedures and rationale for specific therapies in chronic kidney disease-mineral and bone disorder.

Bover J, Canal C, Marco H, Fernandez-Llama P, Bosch RJ, Ballarín J. Bover J, et al. Contrib Nephrol. 2008;161:222-233. doi: 10.1159/000130690. Contrib Nephrol. 2008. PMID: 18451681 Review.

6

[Tables estimating glomerular filtration rate from plasma creatinine].

Canal C, Pellicer R, Rocha CI, Calero F, Gracia S, Montañés R, Ballarín J, Bover J. Canal C, et al. Among authors: bover j. Nefrologia. 2008;28(3):317-24. Nefrologia. 2008. PMID: 18590499 Free article. Spanish.

7

Update on the treatment of chronic kidney disease-mineral and bone disorder.

Bover J, Farré N, Andrés E, Canal C, Olaya MT, Alonso M, Quílez B, Ballarín J. Bover J, et al. J Ren Care. 2009 Mar;35 Suppl 1:19-27. doi: 10.1111/j.1755-6686.2009.00049.x. J Ren Care. 2009. PMID: 19222727 Review.

8

Calcimimetics in the chronic kidney disease-mineral and bone disorder.

Bover J, Aguilar A, Baas J, Reyes J, Lloret MJ, Farré N, Olaya M, Canal C, Marco H, Andrés E, Trinidad P, Ballarin J. Bover J, et al. Int J Artif Organs. 2009 Feb;32(2):108-21. doi: 10.1177/039139880903200208. Int J Artif Organs. 2009. PMID: 19363783 Review.

9

Role of vitamin D receptor activators in peritoneal dialysis.

Bover J, Lloret MJ, DaSilva I, Furlano M, Díaz M, Herreros A, Cozzolino M, Ballarín J. Bover J, et al. Contrib Nephrol. 2012;178:124-142. doi: 10.1159/000337832. Epub 2012 May 25. Contrib Nephrol. 2012. PMID: 22652728 Review.

10

Clinical Uses of 1,25-dihydroxy-19-nor-vitamin D(2) (Paricalcitol).

Bover J, Dasilva I, Furlano M, Lloret MJ, Diaz-Encarnacion MM, Ballarin J, Cozzolino M. Bover J, et al. Curr Vasc Pharmacol. 2014 Mar;12(2):313-23. doi: 10.2174/15701611113119990028. Curr Vasc Pharmacol. 2014. PMID: 23713879 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

177 results

Search Page

Filters